In hemodialysis patient with secondary hyperparathyroidism, higher baseline serum FGF23 levels are associated with an increased risk for the primary outcome (death, first myocardial infarction, hospitalization for unstable angina, heart failure or peripheral vascular event) [188]. This evidence concerns the gene FGF23 and heart failure.